Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
- PMID: 36346569
- PMCID: PMC9668964
- DOI: 10.1007/s12185-022-03485-8
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Figures
Erratum for
-
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.Int J Hematol. 2022 Nov;116(5):647-658. doi: 10.1007/s12185-022-03401-0. Epub 2022 Jul 6. Int J Hematol. 2022. PMID: 35790696 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
